Northern Trust Corp Oyster Point Pharma, Inc. Call Options Transaction History
Northern Trust Corp
- $600 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OYST
# of Institutions
4Shares Held
19KCall Options Held
0Put Options Held
0About Oyster Point Pharma, Inc.
- Ticker OYST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,831,500
- Description
- Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...